98%
921
2 minutes
20
Background: Heart failure is a major cause of morbidity and mortality worldwide; left ventricular diastolic dysfunction plays a leading role in this clinical context. Diastolic dysfunction may be predisposed by increased abdominal fat and, consequently, increased pericardial and epicardial adiposity. This study aimed to determine whether pericardial fat (PF) and epicardial fat (EF) are associated with left ventricular diastolic function.
Methods: A total of 82 patients had their abdominal circumference measured and underwent transthoracic echocardiography to measure the thickness of PF and EF and assess the left ventricular diastolic function. Two groups were created based on mean pericardial fat (PF) thickness (4.644 mm) and were related to abdominal circumference and echocardiographic parameters.
Results: Subjects in the PF High group showed a significant decrease in septal e' ( < 0.0001), lateral e' ( < 0.0001), and E/A ratio ( = 0.003), as well as a significant increase in E/e' ratio ( < 0.0001), E wave deceleration time ( = 0.013), left atrial volume ( < 0.0001), the left ventricle mass ( = 0.003), tricuspid regurgitant jet velocity ( < 0.0001), and the left ventricle diameter ( = 0.014) compared to the PF Low group. Correlations were found between pericardial fat and nine echocardiographic parameters in the study, while epicardial fat (EP) only correlated with eight.
Conclusions: Measurement of abdominal circumference, PF, and EF is an early indicator of diastolic changes with transthoracic echocardiography being the gold standard exam.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11012189 | PMC |
http://dx.doi.org/10.3390/diagnostics14070702 | DOI Listing |
Heart Lung Circ
September 2025
Baker Heart and Diabetes Institute, Melbourne, Vic, Australia; Victorian Heart Hospital, Melbourne, Vic, Australia; Victorian Heart Institute, Melbourne, Vic, Australia. Electronic address:
Epicardial adipose tissue (EAT) is the layer of fat located between the visceral pericardium and the myocardium. Emerging research has signified its role in the development of various cardiovascular diseases. The pathogenesis is complex, involving various bioactive compounds that have been implicated in the development of coronary artery disease, heart failure, and arrhythmogenesis.
View Article and Find Full Text PDFJ Am Coll Cardiol
September 2025
Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Background: Incretin-based therapies are used to treat type 2 diabetes and obesity, but the presence of diabetes diminishes the magnitude of weight loss produced by these drugs in people with obesity. It is not known whether this attenuated weight change is relevant to the clinical benefits of these drugs in heart failure.
Objectives: The goal of this study was to assess the influence of diabetes on the efficacy and safety of tirzepatide in the SUMMIT trial.
Int J Mol Sci
August 2025
Department of Endocrinology, Centre of Postgraduate Medical Education, Marymoncka St. 99/103, 01-813 Warsaw, Poland.
Obesity is strongly associated with an increased risk of heart failure. Recent studies indicate that epicardial adipose tissue plays a critical role in the development of obesity-related cardiomyopathy. This distinct visceral fat depot, located between the myocardium and the visceral pericardium, is involved in direct cross-talk with the adjacent myocardium, influencing both its structural integrity and electrophysiological function.
View Article and Find Full Text PDFCancers (Basel)
August 2025
Department of Oncology, Rigshospitalet, 2100 Copenhagen, Denmark.
Background/objectives: No reliable noninvasive biomarkers are available to predict RT-induced cardiotoxicity. Because the pericardial sac is a fast responder to cardiac injury, we investigated whether RT-induced radiographic pericardial changes might serve as early imaging biomarkers for late cardiotoxicity.
Methods: We performed a retrospective study of 476 patients (210 males, 266 females; median age, 69 years; median follow-up, 26.
J Magn Reson Imaging
August 2025
Department of Pediatric Cardiology, Instituto de Cardiologia e Transplantes Do Distrito Federal, Brasília, Brazil.